Understanding the role of GAPs in cancer has opened new avenues for therapeutic interventions. Targeting the pathways regulated by GAPs can help develop novel treatments. For instance, MEK inhibitors and RAF inhibitors are being explored to counteract the hyperactive Ras signaling in cancers associated with NF1 mutations.
